Westover Medical leads UK charge for Biophysical's biomarkers test
This article was originally published in Clinica
Executive Summary
Biophysical, a US developer of biomarker-based technologies, is set to make its much-publicised Biophysical250 test available in the UK through an exclusive licensing deal with Westover Medical. The deal, of which financial terms were not disclosed, will see Westover, a UK private healthcare provider, offer the test in its two existing clinics in London and in a third to be opened in the capital later this year.